Product Information
LORAZEPAM INTENSOL 2 MG/ML is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $0.6863 per ML under NDC 00054353244. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Jun 28, 1991. Its Orange Book therapeutic-equivalence code is AA.
Strength
2 mg/mL
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00054353244
Classification
Generic
Dosage Form
SOLUTION, CONCENTRATE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LORAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA072755FDA Approved
6/28/1991
TE Code
AA
On Market Since
6/28/1991
Pharmacological Classes
Price Statistics
The NADAC for LORAZEPAM INTENSOL 2 MG/ML has been published 671 times since Nov 28, 2013, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6863 per ML |
|---|---|
| All-time high | $0.8544 (Mar 12, 2014) |
| All-time low | $0.5070 (May 23, 2018) |
| 52-week high | $0.6928 |
| 52-week low | $0.6214 |
| Median price | $0.6251 |
| Average price | $0.6290 |
| Largest weekly change | +21.5% (May 17, 2023) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Lorazepam market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Hikma Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Lorazepam market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Benzodiazepine class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LORAZEPAM INTENSOL 2 MG/ML?
The current National Average Drug Acquisition Cost (NADAC) for LORAZEPAM INTENSOL 2 MG/ML, manufactured by Hikma Pharmaceuticals USA Inc., is $0.6863 per ML (NDC 00054353244), effective Sep 30, 2026.
How has the price of LORAZEPAM INTENSOL 2 MG/ML changed over time?
Over the history we have for it, the NADAC for LORAZEPAM INTENSOL 2 MG/ML has held within roughly two percent of its current level. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for LORAZEPAM INTENSOL 2 MG/ML?
Since Nov 28, 2013, the NADAC for LORAZEPAM INTENSOL 2 MG/ML has ranged from a low of $0.5070 (May 23, 2018) to a high of $0.8544 (Mar 12, 2014), with a median of $0.6251 per ML.
Are there cheaper alternatives to LORAZEPAM INTENSOL 2 MG/ML?
No other NADAC-published product currently shares the active ingredient and strength of LORAZEPAM INTENSOL 2 MG/ML in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures LORAZEPAM INTENSOL 2 MG/ML?
LORAZEPAM INTENSOL 2 MG/ML (NDC 00054353244) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.